MRK
Merck$126.19
MRK info0.36%ย โ€ข 24 H
Dividend Yield:2.2%
Global Rank#29
Market Cap$319.51B
YTD Performance15.60%
P/E22.10
Revenue$59.28B
Change 7d0.26%
SP500 BenchmarkOutperform
P/S5.39
Earnings$14.53B

Merck (MRK) Stock Overview

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV, as well as a collaboration with Bionomics to identify novel a7 nAChR PAMs suitable for the treatment of cognitive disorder; and clinical trial collaboration and supply agreement with Ankyra Therapeutics to evaluate ANK-101 in combination with KEYTRUDA (pembrolizumab) in patients with advanced solid tumors, as well as a clinical trial collaboration and supply agreement with Phanes Therapeutics, Inc. to evaluate PT886 in combination with KEYTRUDA for the treatment of claudin 18.2 positive gastric or gastroesophageal junction adenocarcinomas, as well as a development and commercialization agreement with Daiichi Sankyo Company, Limited to jointly develop and commercialize Daiichi Sankyo's DXd antibody drug conjugate (ADC) candidates and a collaboration with HiberCell, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

MRK Stock Information

SymbolMRK
Address
126 East Lincoln AvenueRahway, NJ 07065United States
Founded-
Trading hours9:30 AM - 4:00 PM ET
Websitehttps://www.merck.com
Country๐Ÿ‡บ๐Ÿ‡ธ United States
Phone Number908 740 4000

Merck (MRK) Price Chart

-
Value:-

Merck Overview: Key Details and Summary

Stock data
2022
Change
Price
$126.19
N/A
Market Cap
$319.51B
N/A
Shares Outstanding
2.53B
0.08%
Employees
67.00K
N/A
Shareholder Equity
46.06B
20.39%
Valuation
2022
Change
P/E Ratio
22.10
N/A
P/S Ratio
5.39
N/A
P/B Ratio
6.94
N/A
P/FCF
21.73
N/A
Dividends
2022
Change
Dividend Yield
2.19%
N/A
Dividend per share
2.7694
N/A
Dividend Payout Ratio
0.4827
N/A
Growth
2022
Change
ROIC
0.1598
N/A
Return on Equity
0.3154
N/A
Earnings
2022
Change
Revenue
$59.28B
N/A
Earnings
$14.53B
N/A
Free Cash Flow
$14.71B
N/A
EPS
5.71
N/A
Earnings Yield
0.0452
N/A
Gross Margin
0.7063
N/A
Operating Margin
0.3084
N/A
Net income margin
0.245
N/A
FCF Margin
0.2481
N/A
Financial Strength
2022
Change
Total Assets
$109.16B
N/A
Total Debt
$30.69B
N/A
Cash on Hand
$13.19B
N/A
Debt to Equity
$1.37
-22.28%
Cash to Debt
0.4298
75.75%
Current Ratio
$1.47
16.24%
Other data
2022
Change
Buyback Yield
0.0000
N/A
ยฉ 2024 TopStocks.org
Facebook Icon
Twitter Icon
Linkedin Icon